Esophageal carcinoma and achalasia

Prevalence, incidence and results of treatment

A. Peracchia, A. Segalin, R. Bardini, A. Ruol, L. Bonavina, M. Beassato

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Between 1980 and 1988, we treated 1,521 patients with squamous cell carcinoma of the esophagus and 336 patients with adenocarcinoma of the gastric cardia. Between 1967 and 1988, 244 patients with esophageal achalasia were also observed. Among 1,857 patients with cancer, achalasia was present in 21 cases (1.1%). In 18 patients the mean and median interval between the diagnosis of achalasia and cancer was 11.5 and 8 years, respectively. In 3 cases achalasia was detected during the work-up for esophageal cancer. The previous treatment for achalasia administered elsewhere was as follows: balloon dilatation in 6 cases, myotomy and Nissen repair in 2, and distal esophageal resection in 1. Thirteen patients (61.9%) underwent resection, resulting in 1 postoperative death, and a mean and median survival of 23.3 and 13 months, respectively. Push intubation was performed in 4 cases, chemotherapy in 2, a by-pass procedure in 1, endoscopic Nd:YAG laser in 1, while 1 further patient did not receive any treatment for the carcinoma, but only balloon dilatation of the LES. The mean follow-up of the 244 patients with primary esophageal achalasia was 44.6 months (range 1-108), and only 1 patient developed an esophageal cancer, giving an incidence of 18.6 cases per 100,000 per year. Conclusions: in our experience, achalasia is present in a minority of patients with esophageal cancer, and larger prospective controlled trials are needed to assess the true incidence of malignant degeneration in the achalasic patient.

Original languageEnglish
Pages (from-to)514-516
Number of pages3
JournalHepato-Gastroenterology
Volume38
Issue number6
Publication statusPublished - 1991

Fingerprint

Esophageal Achalasia
Carcinoma
Incidence
Esophageal Neoplasms
Therapeutics
Dilatation
Cardia
Solid-State Lasers
Intubation
Esophagus
Squamous Cell Carcinoma
Neoplasms
Stomach
Adenocarcinoma

Keywords

  • Achalasia
  • Carcinoma
  • Esophagus

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Peracchia, A., Segalin, A., Bardini, R., Ruol, A., Bonavina, L., & Beassato, M. (1991). Esophageal carcinoma and achalasia: Prevalence, incidence and results of treatment. Hepato-Gastroenterology, 38(6), 514-516.

Esophageal carcinoma and achalasia : Prevalence, incidence and results of treatment. / Peracchia, A.; Segalin, A.; Bardini, R.; Ruol, A.; Bonavina, L.; Beassato, M.

In: Hepato-Gastroenterology, Vol. 38, No. 6, 1991, p. 514-516.

Research output: Contribution to journalArticle

Peracchia, A, Segalin, A, Bardini, R, Ruol, A, Bonavina, L & Beassato, M 1991, 'Esophageal carcinoma and achalasia: Prevalence, incidence and results of treatment', Hepato-Gastroenterology, vol. 38, no. 6, pp. 514-516.
Peracchia A, Segalin A, Bardini R, Ruol A, Bonavina L, Beassato M. Esophageal carcinoma and achalasia: Prevalence, incidence and results of treatment. Hepato-Gastroenterology. 1991;38(6):514-516.
Peracchia, A. ; Segalin, A. ; Bardini, R. ; Ruol, A. ; Bonavina, L. ; Beassato, M. / Esophageal carcinoma and achalasia : Prevalence, incidence and results of treatment. In: Hepato-Gastroenterology. 1991 ; Vol. 38, No. 6. pp. 514-516.
@article{1d83b6cd237844c6a7a577544c767cfd,
title = "Esophageal carcinoma and achalasia: Prevalence, incidence and results of treatment",
abstract = "Between 1980 and 1988, we treated 1,521 patients with squamous cell carcinoma of the esophagus and 336 patients with adenocarcinoma of the gastric cardia. Between 1967 and 1988, 244 patients with esophageal achalasia were also observed. Among 1,857 patients with cancer, achalasia was present in 21 cases (1.1{\%}). In 18 patients the mean and median interval between the diagnosis of achalasia and cancer was 11.5 and 8 years, respectively. In 3 cases achalasia was detected during the work-up for esophageal cancer. The previous treatment for achalasia administered elsewhere was as follows: balloon dilatation in 6 cases, myotomy and Nissen repair in 2, and distal esophageal resection in 1. Thirteen patients (61.9{\%}) underwent resection, resulting in 1 postoperative death, and a mean and median survival of 23.3 and 13 months, respectively. Push intubation was performed in 4 cases, chemotherapy in 2, a by-pass procedure in 1, endoscopic Nd:YAG laser in 1, while 1 further patient did not receive any treatment for the carcinoma, but only balloon dilatation of the LES. The mean follow-up of the 244 patients with primary esophageal achalasia was 44.6 months (range 1-108), and only 1 patient developed an esophageal cancer, giving an incidence of 18.6 cases per 100,000 per year. Conclusions: in our experience, achalasia is present in a minority of patients with esophageal cancer, and larger prospective controlled trials are needed to assess the true incidence of malignant degeneration in the achalasic patient.",
keywords = "Achalasia, Carcinoma, Esophagus",
author = "A. Peracchia and A. Segalin and R. Bardini and A. Ruol and L. Bonavina and M. Beassato",
year = "1991",
language = "English",
volume = "38",
pages = "514--516",
journal = "Acta hepato-splenologica",
issn = "0172-6390",
publisher = "H.G.E. Update Medical Publishing Ltd.",
number = "6",

}

TY - JOUR

T1 - Esophageal carcinoma and achalasia

T2 - Prevalence, incidence and results of treatment

AU - Peracchia, A.

AU - Segalin, A.

AU - Bardini, R.

AU - Ruol, A.

AU - Bonavina, L.

AU - Beassato, M.

PY - 1991

Y1 - 1991

N2 - Between 1980 and 1988, we treated 1,521 patients with squamous cell carcinoma of the esophagus and 336 patients with adenocarcinoma of the gastric cardia. Between 1967 and 1988, 244 patients with esophageal achalasia were also observed. Among 1,857 patients with cancer, achalasia was present in 21 cases (1.1%). In 18 patients the mean and median interval between the diagnosis of achalasia and cancer was 11.5 and 8 years, respectively. In 3 cases achalasia was detected during the work-up for esophageal cancer. The previous treatment for achalasia administered elsewhere was as follows: balloon dilatation in 6 cases, myotomy and Nissen repair in 2, and distal esophageal resection in 1. Thirteen patients (61.9%) underwent resection, resulting in 1 postoperative death, and a mean and median survival of 23.3 and 13 months, respectively. Push intubation was performed in 4 cases, chemotherapy in 2, a by-pass procedure in 1, endoscopic Nd:YAG laser in 1, while 1 further patient did not receive any treatment for the carcinoma, but only balloon dilatation of the LES. The mean follow-up of the 244 patients with primary esophageal achalasia was 44.6 months (range 1-108), and only 1 patient developed an esophageal cancer, giving an incidence of 18.6 cases per 100,000 per year. Conclusions: in our experience, achalasia is present in a minority of patients with esophageal cancer, and larger prospective controlled trials are needed to assess the true incidence of malignant degeneration in the achalasic patient.

AB - Between 1980 and 1988, we treated 1,521 patients with squamous cell carcinoma of the esophagus and 336 patients with adenocarcinoma of the gastric cardia. Between 1967 and 1988, 244 patients with esophageal achalasia were also observed. Among 1,857 patients with cancer, achalasia was present in 21 cases (1.1%). In 18 patients the mean and median interval between the diagnosis of achalasia and cancer was 11.5 and 8 years, respectively. In 3 cases achalasia was detected during the work-up for esophageal cancer. The previous treatment for achalasia administered elsewhere was as follows: balloon dilatation in 6 cases, myotomy and Nissen repair in 2, and distal esophageal resection in 1. Thirteen patients (61.9%) underwent resection, resulting in 1 postoperative death, and a mean and median survival of 23.3 and 13 months, respectively. Push intubation was performed in 4 cases, chemotherapy in 2, a by-pass procedure in 1, endoscopic Nd:YAG laser in 1, while 1 further patient did not receive any treatment for the carcinoma, but only balloon dilatation of the LES. The mean follow-up of the 244 patients with primary esophageal achalasia was 44.6 months (range 1-108), and only 1 patient developed an esophageal cancer, giving an incidence of 18.6 cases per 100,000 per year. Conclusions: in our experience, achalasia is present in a minority of patients with esophageal cancer, and larger prospective controlled trials are needed to assess the true incidence of malignant degeneration in the achalasic patient.

KW - Achalasia

KW - Carcinoma

KW - Esophagus

UR - http://www.scopus.com/inward/record.url?scp=0026354461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026354461&partnerID=8YFLogxK

M3 - Article

VL - 38

SP - 514

EP - 516

JO - Acta hepato-splenologica

JF - Acta hepato-splenologica

SN - 0172-6390

IS - 6

ER -